Is It Prime Time for Statin Therapy in Psoriasis?

Affiliations

¹ Section of Inflammation and Cardiovascular Diseases, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Maryland, USA. Electronic address: nehal.mehta@nih.gov.
² Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Comment

Nehal N Mehta et al. J Invest Dermatol. 2022 Jun.

. 2022 Jun;142(6):1519-1522.

doi: 10.1016/j.jid.2022.02.020.

¹ Section of Inflammation and Cardiovascular Diseases, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Maryland, USA. Electronic address: nehal.mehta@nih.gov.
² Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

No abstract available

Comment on

A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation.
Garshick MS, Drenkova K, Barrett TJ, Schlamp F, Fisher EA, Katz S, Jelic S, Neimann AL, Scher JU, Krueger J, Berger JS. Garshick MS, et al. J Invest Dermatol. 2022 Jun;142(6):1749-1752.e4. doi: 10.1016/j.jid.2021.07.190. Epub 2021 Nov 19. J Invest Dermatol. 2022. PMID: 34808233 Free PMC article. Clinical Trial. No abstract available.